We show that LY6D+ tumor cells lie on a differentiation spectrum between BCC and SCCs, and resemble basosquamous cell carcinoma (BSC), highlighting pathway switching as a cellular plasticity-mediated resistance mechanism. The gene discussed is LY6D; the disease is neoplasm.